Skip to Content

ULTRASE MT 20 (Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease)

Generic Name: pancrelipase

Pill with imprint ULTRASE MT 20 is Gray / Yellow, Capsule-shape and has been identified as Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease. It is supplied by Axcan Scandipharm Inc..

Ultrase MT 20 is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for ULTRASE MT 20

Ultrase MT 20

Generic Name
pancrelipase
Imprint
ULTRASE MT 20
Strength
65,000 units amylase; 20,000 units lipase; 65,000 units protease
Color
Gray / Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Axcan Scandipharm Inc.
National Drug Code (NDC)
58914-0004

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.